Integrating cardiac fibrosis into heart failure management remains an unmet medical need due to high tissue heterogeneity, clinical diversity, and limitations in diagnosis and treatment.
Integrating cardiac fibrosis management into heart failure care remains a major unmet need due to diagnostic and therapeutic limitations.
Cardiac fibrosis is a major driver associated with the growing burden of heart failure, especially in older people. However, integrating cardiac fibrosis in heart failure management is still an unmet medical need, which may be explained by its high tissue heterogeneity and clinical diversity, and, as a consequence, the very real limitations of its diagnosis and treatment. In this viewpoint article we summarize the challenges and requirements in the clinical management of cardiac fibrosis in heart failure patients.
Dı́ez et al. (2021) conducted a review in Heart failure and cardiac fibrosis. Integrating cardiac fibrosis into heart failure management remains an unmet medical need due to high tissue heterogeneity, clinical diversity, and limitations in diagnosis and treatment.